Últimos Artículos de Diabetes, Obesity and Metabolism
- Impact of Sodium‐Glucose Cotransporter‐2 Inhibitors on Quality of Life and Patient‐Reported Outcomes in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta‐Analysis
- Exercise Metabolic Flexibility in Type 2 Diabetes Treated With Empagliflozin: An Exploratory Analysis of the Randomised Trial EMPA‐HEART
- Efficacy and Safety of Apolipoprotein C‐III Inhibitors in Hypertriglyceridemia: A Network Meta‐Analysis of Randomised Controlled Trials
- Current Trends in the Epidemiology of Obesity and the Association Between Obesity and Metabolic Liver Disease (MASLD/MASH)
- Albuminuria and Carotid Atherosclerosis in Type 1 Diabetes Evaluated Using Three‐Dimensional Vascular Ultrasound
- Swimming With the Omnipod 5 Automated Insulin Delivery System: An Observational Investigation of Swimmers With Type 1 Diabetes in the Omnipod 5 Pivotal Trial
- Artificial Intelligence in Diabetes Care
- Glycaemic Outcomes of a Novel Model‐Predictive‐Control‐Based Hybrid Closed‐Loop System in Chinese Adolescents and Adults With Type 1 Diabetes: A Multicentre Pivotal Trial
- Concurrence of the Core Mechanistic Tenets of the American Heart Association Statement on the Cardiovascular–Kidney–Metabolic Syndrome and the Adipokine Hypothesis of Heart Failure With Preserved Ejection Fraction
- Why Lifestyle Alone Is Insufficient in Obesity: Biological Evidence, Conceptual Analogies and a Legacy of Missed Opportunities in Patient Care
- Downstream Treatment Burden and Health‐Care Utilization Following Initiation of GLP‐1 Receptor Agonists or SGLT2 Inhibitors in Type 2 Diabetes
- Toward Personalized Medicine in Type 1 Diabetes: Understanding How Patient Heterogeneity Influences Therapeutic Efficacy
- The Risk of Disease Progression of Type 1 Diabetes in First‐Degree Relatives of People With Type 1 Diabetes: Design and Rationale of a Prospective, Longitudinal Study in China
- From Screening to Delivery of Disease‐Modifying Therapy: Real World Follow‐Up of Children With Early‐Stage Type 1 Diabetes
- Efficacy, Safety and Pharmacokinetics of Semaglutide 1.7 mg for Obesity Treatment in Adolescents: A Model‐Informed Drug Development Approach
- Effect of Metformin Treatment on Gonadotropin Levels in Women With Polycystic Ovary Syndrome: A Systematic Review and Meta‐Analysis of 51 Randomised Controlled Trials
- Real‐World Cardiovascular Outcomes of Obesity Treatment With Tirzepatide Versus Semaglutide in Non‐Diabetic Adults
- Glycemic Variability Bridges Time in Range and Time in Tight Range: A Unified Equation for Both Type 1 and Type 2 Diabetes Based on Large‐Scale Continuous Glucose Monitoring Data
- Efficacy and Safety of Automated Insulin Delivery in People With Type 2 Diabetes: A Systematic Review and Meta‐Analysis
- Lower Risk of Cardiovascular Events in Patients With Clinical Atherosclerotic Cardiovascular Disease Who Initiated Semaglutide 2.4 mg in the Real‐World: Results From the SCORE—Clinical ASCVD Study